Federal Supply Schedule 36F79718D0422

Award Date 5/15/18
Last Date to Order 9/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule contract awarded by the U.S. Department of Veterans Affairs (VA) to Ibsa Pharma Inc., a foreign-owned for-profit organization. The contract, classified under FSS-61-IB, is for the provision of pharmaceuticals, drugs, and hematology-related products. The contract has a ceiling value of $1,020,000.00 and a period of performance from May 15, 2019, to January 31, 2026. As a Federal Supply Schedule contract, it is a multiple-award vehicle that allows other government...
The Federal Supply Schedule (FSS) contract 36F79722D0065 was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Organon LLC, a pharmaceutical company. The contract has a ceiling value of $1,500,000.00 and a period of performance through July 14, 2027. The purpose of this FSS contract is to provide the VA, Defense Health Agency, Bureau of Prisons, and Indian Health Service with a range of drugs, pharmaceuticals, and hematology-related products under the...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business, is for the delivery of pharmaceutical and hematology-related products under Federal Supply Class 65 I B. The contract has a ceiling value of $225,000 and a period of performance through May 2028. In addition to the FSS contract, Nobelpharma America, LLC holds a single-award Blanket Purchase Agreement...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Santen Inc. for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under Schedule 65 I B. The $1,025,000.00 contract has a period of performance through March 31, 2023 and was awarded on April 3, 2022. As an FSS contract, this is a multiple award vehicle that allows the VA and other federal agencies to place task orders for the specified pharmaceutical and medical...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract award, Contract ID 36F79724D0187, was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a total ceiling value of $250,000.00 and will run through August 31, 2029. The purpose of this multiple-award FSS contract is to procure Drugs, Pharmaceuticals, and Hematology Related Products (FSC 65 I B) from the prime contractor, Sentynl Therapeutics, Inc. The...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Pierre Fabre Pharmaceuticals, Inc., a for-profit manufacturer. The contract has a ceiling value of $1,210,900.00 and a period of performance through September 26, 2029. The contract is for 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, which indicates that the scope covers a wide range of pharmaceutical and hematology-related products....
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...

The Federal Supply Schedule (FSS) contract 36F79718D0422 was awarded by the Department of Veterans Affairs (VA) to Ipsen Biopharmaceuticals Inc. for the procurement of pharmaceutical and drug products, specifically the drug SOHONOS. The contract has a total ceiling value of $316,000,000 and a period of performance through September 30, 2025.

The contract includes a Blanket Purchase Agreement (BPA) with a ceiling value of $535,300 and a period of performance through April 2, 2026. The BPA was awarded under the GSA FSS 61-IB for Pharmaceuticals and Drugs to allow the VA to place individual task orders against the master agreement to meet its needs for the SOHONOS product over the contract's period of performance. The contract does not utilize any set-asides and was awarded as a multiple award.

Generated 7/27/25, 12:46 AM